Surreal illustration of the brain's network affected by environmental toxins.

Decoding the Impact of Environmental Toxins: How Integrated Models Are Changing Risk Assessment

"Exploring the intersection of PBPK/PD models, system biology, and miRNA-BDNF pathways to understand and mitigate neurotoxicity from environmental exposures."


In the realm of toxicology, accurately assessing the risks posed by environmental contaminants is a complex challenge. Traditional methods often fall short in capturing the intricate interactions between chemicals and our biological systems. However, a new frontier has emerged: integrated computational toxicology. This innovative approach combines dynamic signal transduction pathways with tissue dosimetry models, offering a more holistic view of how toxins affect our health.

One significant advancement involves coupling physiological based pharmacokinetics and pharmacodynamics (PBPK/PD) models with system biology. This integration allows researchers to delve deeper into the kinetics of both chemicals and biomolecules, unraveling the dynamic behaviors of molecular pathways when exposed to toxins. By understanding these complex interactions, we can better predict and mitigate potential health risks.

This article explores how an integrated PBPK/PD model, coupled with the miRNA-BDNF pathway, is being used to study the neurotoxic effects of perfluorooctanesulfonic acid (PFOS). This approach highlights the critical role of miRNA-mediated BDNF regulation in controlling neuronal cell proliferation, differentiation, and survival, providing new insights into how environmental toxins impact our brains.

Understanding PBPK/PD Models: A Key to Modern Toxicology

Surreal illustration of the brain's network affected by environmental toxins.

The journey of quantitative risk assessment has led to the development of sophisticated models designed to quantify and estimate potential health risks. Among these, the Physiological Based Pharmacokinetic and Pharmacodynamic (PBPK/PD) models stand out as essential tools. PBPK models quantify internal biophase concentrations in different tissues, while PD models describe how chemicals interact with target biomolecules. System Biology enhances this framework by detailing the dynamic relationships of biological components, providing a robust view of physiological responses.

Integrating PBPK/PD models with system biology offers a predictive tool for measuring toxicological impacts at cellular and biomolecular levels. This approach has become increasingly vital in the 21st century, marking a significant step forward in toxicity testing and risk assessment.

  • PBPK Models: Quantify internal chemical concentrations in various tissues.
  • PD Models: Describe chemical interactions with target biomolecules.
  • System Biology: Details the dynamic relationships of biological components.
  • Integration: Provides a predictive tool for assessing toxicological impacts at cellular and biomolecular levels.
The PBPK model has been widely accepted and applied in dosimetry risk assessment. For example, PBPK/PD models have been developed for certain pesticides, integrating pharmacodynamics to quantify the effects of chemical interactions on biomarkers.

The Future of Toxicology: Integrated Models for Enhanced Risk Assessment

The integration of PBPK/PD models with mechanistic system pathways represents a significant advancement in toxicology. By assessing the impact of environmental chemicals on biological systems through these integrated models, scientists can better understand and predict potential adverse outcomes. This approach not only enhances our ability to quantify risk but also provides a more comprehensive understanding of the underlying biological processes, paving the way for more effective strategies to protect public health.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/j.toxlet.2017.08.003, Alternate LINK

Title: Developing Integrated Pbpk/Pd Coupled Mechanistic Pathway Model (Mirna-Bdnf): An Approach Towards System Toxicology

Subject: Toxicology

Journal: Toxicology Letters

Publisher: Elsevier BV

Authors: Raju Prasad Sharma, Marta Schuhmacher, Vikas Kumar

Published: 2017-10-01

Everything You Need To Know

1

What are PBPK/PD models, and how are they used in assessing the risks of environmental toxins?

Physiologically Based Pharmacokinetic and Pharmacodynamic (PBPK/PD) models are essential tools in modern toxicology for quantifying and estimating potential health risks from environmental toxins. PBPK models quantify internal chemical concentrations in various tissues, determining the distribution of toxins within the body. PD models describe how chemicals interact with target biomolecules, elucidating the effects of these toxins at a molecular level. These models enhance risk assessment by providing a detailed understanding of how toxins affect the body, leading to more accurate predictions of adverse health outcomes. The integration of PBPK/PD models with system biology allows for a robust view of physiological responses, marking a significant advancement in toxicity testing.

2

How does system biology enhance PBPK/PD models in the context of toxicology?

System biology enhances PBPK/PD models by detailing the dynamic relationships of biological components. This integration provides a more comprehensive view of physiological responses to environmental toxins. By incorporating system biology, researchers can understand not only how chemicals distribute within the body (via PBPK models) and interact with target biomolecules (via PD models) but also how these interactions affect complex biological pathways and networks. This holistic approach allows for a more predictive assessment of toxicological impacts at cellular and biomolecular levels, improving the accuracy and reliability of risk assessments.

3

What is the significance of the miRNA-BDNF pathway in understanding neurotoxicity from environmental exposures, particularly in the context of integrated models?

The miRNA-BDNF pathway plays a critical role in controlling neuronal cell proliferation, differentiation, and survival. Its significance in understanding neurotoxicity from environmental exposures lies in its ability to reveal how environmental toxins, such as perfluorooctanesulfonic acid (PFOS), impact brain health at a molecular level. By integrating the miRNA-BDNF pathway with PBPK/PD models, scientists can gain new insights into the mechanisms through which toxins disrupt neurological functions. This integrated approach highlights the importance of miRNA-mediated BDNF regulation and provides a more comprehensive understanding of how environmental toxins contribute to neurotoxic effects.

4

In what ways do integrated computational toxicology approaches, specifically combining PBPK/PD models with system biology, offer improvements over traditional toxicology methods?

Integrated computational toxicology approaches that combine PBPK/PD models with system biology offer several key improvements over traditional toxicology methods. Traditional methods often fall short in capturing the intricate interactions between chemicals and biological systems. In contrast, integrated models provide a more holistic view by combining dynamic signal transduction pathways with tissue dosimetry models. This allows researchers to delve deeper into the kinetics of chemicals and biomolecules, unraveling the dynamic behaviors of molecular pathways when exposed to toxins. The integration of PBPK/PD models with system biology offers a predictive tool for measuring toxicological impacts at cellular and biomolecular levels, enabling a more accurate and comprehensive assessment of potential health risks.

5

How are PBPK/PD models currently being applied in dosimetry risk assessment, and what are some specific examples of their use?

PBPK/PD models are widely accepted and applied in dosimetry risk assessment to quantify the effects of chemical interactions on biomarkers. For example, PBPK/PD models have been developed for certain pesticides, integrating pharmacodynamics to assess the impact of these chemicals on biological systems. These models are used to quantify internal biophase concentrations in different tissues, providing a detailed understanding of how chemicals distribute within the body and interact with target biomolecules. This approach enhances our ability to predict potential adverse outcomes and develop more effective strategies to protect public health. The use of PBPK/PD models in dosimetry risk assessment represents a significant step forward in toxicity testing and risk assessment, allowing for a more comprehensive and accurate evaluation of the risks posed by environmental chemicals.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.